Diagnostic reference levels and effective dose in paediatric cardiac catheterization

European states within the EEC are required to establish and use diagnostic reference levels (DRLs) in X-ray examinations. However, up to now there have been no DRLs for cardiac catheterization in children, nor as a rule is the effective dose estimated. We have evaluated the dose-area products (DAPs) for three different types of angiocardiography systems over a time span of 8 years. For each system DAP increased in proportion to the body weight (BW) over two orders of magnitude. The proportionality constant decreased over the years. To reduce the broad distribution of DAP the doses for cine acquisition (DAPA) and fluoroscopy (DAPF) were indexed with respect to the total numbers of acquired images (AN) and the total times of fluoroscopy (FT). DAPA/AN is directly proportional to BW with a high correlation (r = 0.896, n = 1346). Likewise, DAPF/FT is proportional to BW from 0.1 kg to 100 kg (r = 0.84, n = 2138). Therefore, by normalizing DAP to BW the growth dependent variation of DAP can be eliminated. There are numerous short examinations with very small total DAPs, which were separated from the group of diagnostic examinations. The mean DAP/BW of this group is 0.41 Gycm2 kg(-1) (90th percentile: 0.81 Gycm2 kg(-1), n = 1106). For interventional procedures in congenital heart diseases DAP/BW is significantly higher (p<0.001) (mean: 0.56 Gycm2 kg(-1), 90th percentile: 1.16 Gycm2 kg(-1), n = 883). There are significant differences between different types of interventional procedures, the mean values being between 0.35 Gycm2 kg(-1) (occlusion of patent ductus botalli, n = 165) and 1.30 Gycm2 kg(-1) (occlusion of ventricular septal defect, n = 32). For patients who are catheterized several times over the years, the cumulative effective dose (E) may reach high values, being especially high for patients with hypoplastic left heart syndrome (typically 11 mSv). E is derived from DAP/BW by use of a constant DAP/BW to E conversion factor, independent of the age of the patient. DAP/BW is appropriate to describe paediatric DRLs and is recommended instead of using mean DAP values for age groups.     

Skin dose and dose-area product values in patients undergoing intracoronary brachytherapy

Entrance skin doses, dose-area product (DAP) values, fluoroscopy times and digital cine acquisition data were measured for 86 patients undergoing intracoronary brachytherapy procedures with beta sources, to estimate risk of skin injuries. Interventions were carried out in three dedicated X-ray interventional cardiology rooms equipped with X-ray systems operating in pulsed modes, with high filtration and edge filter options. Skin dose distribution was analysed in detail in 56 patients using slow films and thermoluminescent dosimetry. Digital recording of Digital Imaging and Communications in Medicine cine images also allowed analysis of the technical parameters used throughout the procedures. A protocol for clinical follow-up of these patients at the cardiology service is also presented, which prescribes special attention when a threshold dose is reached. Median values for DAP, fluoroscopy time and number of frames were 81.2 Gy cm(2), 17.5 min and 1569 frames, respectively, and maximum values were 323.3 Gy cm(2), 46.2 min and 3213 frames, respectively. In two cases, maximum skin doses in a procedure reached 3.5 Gy and 4.6 Gy. Comparing median values in this study, intracoronary brachytherapy involved approximately two-fold the DAP used in percutaneous transluminal coronary angioplasty procedures performed during the same period in the same catheterization laboratories, as a consequence of the need to monitor the radioactive source location used for the treatment of stenoses and the intravascular ultrasound. Special care must be paid in those cases of high dose in relation to potential patient skin injuries and late effects.     

Evaluation of patient-absorbed doses during coronary angiography and intervention by femoral and radial artery access

The aim of this study was to compare the radiation dose to patients during coronary angiography (CA) and coronary intervention (percutaneous transluminal coronary angioplasty, PTCA) by the femoral or radial artery access routes. A plane-parallel ionisation chamber, mounted on an under-couch X-ray tube (Siemens Coroskop TOP with an optional dose reduction system), recorded the dose-area product (DAP) to the patient from 40 coronary angiographies and 42 coronary interventions by the femoral route. The corresponding numbers for radial access were 36 and 24, respectively. Using a human-shaped phantom, conversion factors between maximum entrance surface dose and DAP were derived for CA and CA plus PTCA, respectively. The dose to the staff was measured with TL dosimeters for 22 examinations. Fluoroscopy time and DAP were significantly (p=0.003) larger using the radial access route for coronary angiography (7.5 min, 51 Gy cm²) than the corresponding values obtained from femoral access route (4.6 min, 38 Gy cm²). For CA plus PTCA the fluoroscopy time and DAP were larger for radial access (18.4 min, 75 Gy cm²) than for femoral access (12.5 min, 47 Gy cm²; p=0.013). In our experience, radial access did significantly prolong the fluoroscopy time and increase the patient doses.     

Evaluation of work practices and radiation dose during adult micturating cystourethrography examinations performed using a digital imaging system

A micturating cystourethrography (MCU) examination is a specific radiological procedure that is performed under fluoroscopic screening to visualize the bladder by filling it with contrast material and to evaluate the urethral morphology during voiding. It is necessary to evaluate radiation dose during MCU examination since it involves radiosensitive organs such as the gonads. Radiation dose imparted to 109 patients undergoing MCU examination were measured using a dose-area product (DAP) meter. Patients were categorized into two groups based on whether filling of the bladder with contrast medium was done retrogradely (MCU) or by the suprapubic percutaneous route (SP-MCU). The DAP values to Group A (MCU) and Group B (SP-MCU) patients varied from 0.43 Gycm(2) to 9.26 Gycm(2) and 0.54 Gycm(2) to 9.87 Gycm(2), respectively. Reduction of radiation dose to patients was possible by the use of optimized exposure factors, precise collimation of X-ray beam, use of 0.2 mm copper filters and by acquiring images digitally.     

Skin dose alarm levels in cardiac angiography procedures: is a single DAP value sufficient?

Maximum estimated skin doses to patients undergoing coronary angiography procedures were obtained using radiographic slow film and diode dosemeters. Conversion factors of maximum entrance skin dose versus dose-area product (MESD/DAP) for diagnostic (coronary angiography (CA); 20 patients; 2 operators) and interventional procedures (percutaneous transluminal coronary angiography (PTCA); 10 patients; 1 operator) were 4.3 (mean value of 10 CA; operator A), 3.5 (mean value of 10 CA; operator B) and 9.7 (mean value of 10 PTCA; operator B) mGy(Gycm2)(-1), respectively. The results emphasise a need for both operator- and procedure-specific conversion factors. Compared with a single, global factor for all cardiac procedures and/or operators that is commonly applied today, such a refinement is expected to improve the accuracy in skin dose estimations from these procedures. Consequently, reference DAP values used in the clinic to define patients who could suffer from a radiation induced skin injury following a cardiac procedure, should be defined for each operator/procedure. The film technique was found to be superior to the diode in defining conversion factors in this study, and allowed for a rapid and accurate estimation of MESD for each patient. With appropriate positioning of the diode, a combined film/diode technique has a potential use in the training of new angiography operators. The patient body mass index (BMI) value was a good indicator of the variation in average lung dose (critical organ) between patients. The highest lung dose/DAP value was obtained for normal sized patients (BMI: 19-26), and was close to 1.5 mGy(Gycm2)(-1) with both CA and PTCA procedures.     

Has the introduction of an advanced practitioner led service had an impact on radiation dose for fluoroscopy guided lumbar punctures? A service review

IntroductionHistorically, procedures requiring fluoroscopic guidance such as myelography; barium and video swallows; and fluoroscopy guided lumbar punctures (LP) have been performed by radiologists with the assistance of radiographers. As the National Health Service (NHS) evolves, more responsibilities are being disseminated to specifically trained radiographers to relieve workload due to a national shortage of radiologists. One step taken by the trust was to train an Advanced Practitioner (AP) in fluoroscopy to perform fluoroscopy guided LPs. Clinical audit and service evaluations are required to ensure there is no impact on patient care as a result of changes in practice. Regardless of occupation, healthcare workers undertaking procedures must ensure the same standards of care for patients. Minimising radiation dose is a duty of all radiological professionals.MethodsThis retrospective review evaluated and compared examinations performed by a group of radiologists and an AP in terms of dose area product (DAP) and fluoroscopy screening time. A total of 300 X-ray guided LPs doses were reviewed and comparison between the radiation exposure data sets was performed to determine whether there was a significant difference between the two operator groups.ResultsThe study revealed that AP-performed LPs had a statistically significant lower DAP and fluoroscopy time (a mean of 4.21Gycm2 and 0.74min) compared to the radiologist-performed LPs (a mean of 5.72Gycm2 and 0.94min).ConclusionThe review demonstrates that patient dose is not detrimentally affected by the introduction of an advanced practitioner. It establishes that dose and screening time was significantly lower. It also highlights the effectiveness of APs in an evolving radiology department.Implications for practiceThese outcomes propose advanced practitioners in this area of expertise can expand their role from neuroradiographer with no detriment to patient dose. Despite the results, it is recognised that continuous appraisal is required to ensure that competencies are maintained, and high levels of care are sustained.     

Does digital flat detector technology tip the scale towards better image quality or reduced patient dose in interventional cardiology?

As dynamic flat-panel detectors (FD) are introduced in interventional cardiology (IC), the relation between patient dose and image quality (IQ) needs to be reconsidered for this type of image receptor. On one hand this study investigates IQ of a FD system by means of a threshold contrast-detail analysis and compares it to an image intensifier (II) system on a similar X-ray setup. On the other hand patient dose for coronary angiography (CA) procedures on both systems is compared by Dose-Area Product (DAP)-registration of a patient population. The comparative IQ study was performed for a range of entrance dose rates (EDR) covering the fluoroscopy and cinegraphy working mode. In addition the IQ investigation was extended to a similar study under automatic brightness control (ABC). As well the systematic study of IQ as a function of EDR as the study performed under ABC point to a better IQ for FD in cinegraphy mode and no difference between both systems in fluoroscopy mode. The patient population study resulted in mean DAP values of 31 Gy cm² (II system) and 33 Gy cm² (FD system) (p = 0.68) for CA procedures. As well total DAP as contributions of fluoroscopy and cinegraphy on both systems are not significantly different.To conclude, we could state that profit was taken from the intrinsic better performance of the FD for cinegraphy mode in producing higher quality images in this mode but without any effect on patient dose for CA procedures.     

Preliminary reference levels in interventional cardiology

This article describes the European DIMOND approach to defining reference levels (RLs) for radiation doses delivered to patients during two types of invasive cardiology procedures, namely coronary angiography (CA) and percutaneous transluminal coronary angioplasty (PTCA). Representative centres of six European countries recorded patients' doses in terms of dose-area product (DAP), fluoroscopy time and number of radiographic exposures, using X-ray equipment that has been subject to constancy testing. In addition, a DAP trigger level for cardiac procedures which should alert the operator to possible skin injury, was set to 300 Gy×cm². The estimation of maximum skin dose was recommended in the event that a DAP trigger level was likely to be exceeded. The proposed RLs for CA and PTCA were for DAP 45 Gy×cm² and 75 Gy×cm², for fluoroscopy time 7.5 min and 17 min and for number of frames 1250 and 1300, respectively. The proposed RLs should be considered as a first approach to help in the optimisation of these procedures. More studies are required to establish certain "tolerances" from the proposed levels taking into account the complexity of the procedure and the patient's size.     

心血管介入手术中透视时间作为辐射剂量警示指标的可行性研究

目的以心血管介入术后采集空气比释动能(reference air kerma,AK)值和剂量面积乘积(dose-area product,DAP)值数据为依据,分析术中透视时间报警设置作为心血管介入手术辐射剂量的监测和警示工具的可行性。方法回顾性分析2016年11月至2018年1月上海长海医院736例冠状动脉造影术(CAG)和经皮冠状动脉治疗术(PCI)病例,收集术中透视时间、AK和DAP数据资料。德国西门子成像设备分组(Ceiling系统和Biplane系统)和手术类型分组(CAG和PCI),对辐射剂量数据进行比较,以及对心血管介入手术AK和DAP值与透视时间数据采用Spearman检验解析相关性。结果Ceiling和Biplane成像系统中手术透视时间为(8.9±7.8)和(8.6±7.3)min,透视AK均值和DAP均值分别为(472±474)、(510±509)mGy、(4548±4085)和(4255±3781)μGy·m^2,术中总(透视+造影)AK和DAP均值为(703±595)、(733±614)mGy、(6253±4938)和(5681±4432)μGy·m^2。CAG与PCI术中透视时间均值分别为(2.4±0.9)和(15.7±4.9)min。PCI透视辐射剂量(AK和DAP)与术中总辐射剂量比值分别为74%和78%。心血管介入手术中透视时间与AK值(r=0.822)和DAP值(r=0.844)都呈高度相关性(P<0.001)。结论透视采集辐射剂量是心血管介入手术中辐射剂量的主要来源,辐射剂量随透视时间延长而增加,透视时间监测和报警设置在心血管介入临床应用中作为术中辐射防护工具有一定的参考和警示价值。     

Comparison of Patient Dose in Two-Dimensional Carotid Arteriography and Three-Dimensional Rotational Angiography

Background and Purpose It is known that interventional neuroradiology (IN) involves high radiation dose to both patients and staff even if performed by trained operators using modern fluoroscopic X-ray equipment and dose-reducing technology. Therefore, every new technology or imaging tool introduced, such as three-dimensional rotational angiography (3D RA), should be evaluated in terms of radiation dose. 3D RA requires a series with a large number of images in comparison with 2D angiography and it is sometimes considered a high-dose IN procedure. The literature is scarce on the 3D RA radiation dose and in particular there are no data on carotid arteriography (CA). The aim of this study was to investigate patient dose differences between 2D and 3D CA. Methods The study included 35 patients undergoing 2D CA in hospital 1 and 25 patients undergoing 3D CA in hospital 2. Patient technical data collection included information on the kerma area product (KAP), fluoroscopy time (T), total number of series (S), and total number of acquired images (F). Results Median KAP was 112 Gy cm² and 41 Gy cm² for hospitals 1 and 2, respectively, median T was 8.2 min and 5.1 min, median S was 13 and 4, and median F was 247 and 242. Entrance surface air-kerma rate, as measured in “medium” fluoroscopy mode measured in 2D acquisition using a 20 cm phantom of polymethylmethacrylate, was 17.3 mGy/min for hospital 1 and 9.2 mGy/min for hospital 2. Conclusion 3D CA allows a substantial reduction in patient radiation dose compared with 2D CA, while providing the necessary diagnostic information.     

用胶片法对心脏介入程序中患者峰值皮肤剂量测量研究

目的 采用胶片法对进行心血管介入手术中患者所受峰值皮肤剂量（PSD）进行测量研究,包括冠状动脉血管造影术（CA）和经皮穿刺腔内冠状动脉成形术（PTCA）。方法 选用Gafchromic XR-RV3胶片在两家医院进行患者峰值皮肤剂量的测量。手术时将胶片放在患者身下的诊视床上。记录手术中监视器上显示的kV、mA、透视时间、剂量面积乘积（DAP）、参考点累积剂量等相关信息。采用Epson V750平板扫描仪对胶片进行分析扫描及分析,选用FilmQA软件分别测量图像的红、绿、蓝三色通道的像素值,使用红通道数据计算患者的 PSD。对PSD与设备显示参数进行相关分析,对相关的变量进行多元线性回归分析。结果 共测量CA手术26例,CA+PTCA手术19例。CA手术中,透视时间最高为17.62 min,累积剂量和DAP最大分别为1 498.50 mGy和109.68 Gy ·cm²,PSD最大为361.20 mGy。CA+PTCA手术中,曝光时间最长为64.48 min,累积剂量和DAP最大分别为6 976.20 mGy和5 336.00 Gy ·cm²,17例患者的PSD在1 Gy以内,1例患者PSD在1~2 Gy之间,1例患者PSD超出了发生皮肤损伤2 Gy的阈值,达到了2 195.70 mGy。CA程序中,患者PSD与DAP相关（R²=0.815,P<0.05）,CA+PTCA程序中,患者PSD与累积剂量相关（R²=0.916,P<0.05）。结论 心脏介入放射学程序中部分患者的PSD会超出ICRP建议的发生皮肤确定性效应的2 Gy阈值。DSA设备上显示的剂量相关的参数,只能粗略估算患者PSD的大小。使用XR-RV3胶片精确测量介入手术中患者的峰值皮肤剂量是一种非常快捷、有效的方法。     

X-ray dose and associated risks from radiofrequency catheter ablation procedures

The objectives of this study were to quantify the ionizing radiation exposure to patient and operator during radiofrequency (RF) catheter ablation and to estimate the risks associated with this exposure. The study consisted of 50 RF ablation procedures, all performed in the same electrophysiology laboratory. Occupational dose to two cardiologists who performed the procedures was measured using film badges and extremity thermoluminescent dosemeters (TLDs). Absorbed dose to the patients' skin was measured using TLDs. Dose-area product (DAP) was also measured. The effective dose to the cardiologists was less than 0.15 mSv per month. The mean equivalent dose to the cardiologists' left hand and forehead was 0.24 mSv and 0.05 mSv, respectively, per RF ablation procedure, which was more than twice the mean dose for the other cardiology procedures carried out in the centre. Yearly occupational dose to the cardiologists was much lower than the relevant statutory dose limits. The mean skin dose, fluoroscopy time and DAP to patients were 0.81 Gy, 67 min and 123 Gycm(2), respectively, with a maximum of 3.2 Gy, 164 minutes and 430 Gycm(2), respectively. Mean effective dose to patients was 17 mSv, from which the excess risk of developing fatal cancer is 0.1%. Six of the patients (12%) received a skin dose above the threshold dose for radiation skin injury (2 Gy), but no skin injuries were reported. Patient skin dose and DAP were closely correlated and this allows DAP to be used to monitor patient skin dose in real-time. DAP levels were locally adopted as diagnostic reference levels (DRLs) that provide an indication during a procedure that a patient is at risk of suffering deterministic skin injury.     

The AAPM/RSNA physics tutorial for residents: digital fluoroscopy.

A digital fluoroscopy system is most commonly configured as a conventional fluoroscopy system (tube, table, image intensifier, video system) in which the analog video signal is converted to and stored as digital data. Other methods of acquiring the digital data (eg, digital or charge-coupled device video and flat-panel detectors) will become more prevalent in the future. Fundamental concepts related to digital imaging in general include binary numbers, pixels, and gray levels. Digital image data allow the convenient use of several image processing techniques including last image hold, gray-scale processing, temporal frame averaging, and edge enhancement. Real-time subtraction of digital fluoroscopic images after injection of contrast material has led to widespread use of digital subtraction angiography (DSA). Additional image processing techniques used with DSA include road mapping, image fade, mask pixel shift, frame summation, and vessel size measurement. Peripheral angiography performed with an automatic moving table allows imaging of the peripheral vasculature with a single contrast material injection.     

Effective dose to the patient undergoing superior vena cava stent.

Metallic stents have been recently introduced for treating superior vena cava (SVC) obstruction. Dose data, in terms of dose-area product (DAP), from 44 patients referred for SVC stent placement on a digital unit have been retrospectively analysed in terms of their fluoroscopic and radiographic components. The mean DAP for the 44 examinations was 42 Gy cm2 and the effective dose was estimated to be 5.8 mSv. The fluoroscopic component was approximately 80%, with a mean screening time for these examinations of 17 min. The mean number of digital exposures was 86.     

Relationship between fluoroscopic time, dose-area product, body weight, and maximum radiation skin dose in cardiac interventional procedures

OBJECTIVE: Real-time maximum dose monitoring of the skin is unavailable on many of the X-ray machines that are used for cardiac intervention procedures. Therefore, some reports have recommended that physicians record the fluoroscopic time for patients undergoing fluoroscopically guided intervention procedures. However, the relationship between the fluoroscopic time and the maximum radiation skin dose is not clear. This article describes the correlation between the maximum radiation skin dose and fluoroscopic time for patients undergoing cardiac intervention procedures. In addition, we examined whether the correlations between maximum radiation skin dose and body weight, fluoroscopic time, and dose-area product (DAP) were useful for estimating the maximum skin dose during cardiac intervention procedures. MATERIALS AND METHODS: Two hundred consecutive cardiac intervention procedures were studied: 172 percutaneous coronary interventions and 28 cardiac radiofrequency catheter ablation (RFCA) procedures. The patient skin dose and DAP were measured using Caregraph with skin-dose-mapping software. RESULTS: For the RFCA procedures, we found a good correlation between the maximum radiation skin dose and fluoroscopic time (r = 0.801, p < 0.0001), whereas we found a poor correlation between the maximum radiation skin dose and fluoroscopic time for the percutaneous coronary intervention procedures (r = 0.628, p < 0.0001). There was a strong correlation between the maximum radiation skin dose and DAP in RFCA procedures (r = 0.942, p < 0.0001). There was also a significant correlation between the maximum radiation skin dose and DAP (r = 0.724, p < 0.0001) and weight-fluoroscopic time product (WFP) (r = 0.709, p < 0.0001) in percutaneous coronary intervention procedures. CONCLUSION: The correlation between the maximum radiation skin dose with DAP is more striking than that with fluoroscopic time in both RFCA and percutaneous coronary intervention procedures. We recommend that physicians record the DAP when it can be monitored and that physicians record the fluoroscopic time when DAP cannot be monitored for estimating the maximum patient skin dose in RFCA procedures. For estimating the maximum patient skin dose in percutaneous coronary intervention procedures, we also recommend that physicians record DAP when it can be monitored and that physicians record WFP when DAP cannot be monitored.     

Dose-area product measurements in a range of common orthopaedic procedures and their possible use in establishing local diagnostic reference levels

There is a national drive towards establishing reference doses for radiological procedures with the aim of optimizing patient doses. Furthermore, the establishment of diagnostic reference level doses became a legal requirement for all hospitals on 13 May 2000. However, to date there are little published data on patient radiation doses from fluoroscopic procedures during orthopaedic surgery. Data relating to patient dose for 492 patients undergoing fluoroscopic examinations during a range of surgical orthopaedic procedures in 1997-1998 have been analysed. Median dose-area product (DAP) readings and interquartile ranges for a variety of common fluoroscopic orthopaedic procedures are presented. In general, the median DAP for procedures on limbs and extremities was quite low (0.04-1.62 Gy cm2), with screening times in the range 0.2-2.0 min, whilst for procedures involving the hips and spine the median DAP was considerably higher (0.4-10.2 Gy cm2), although overall screening times were similar, in the range 0.2-1.4 min. Approximate effective doses have been estimated. For procedures involving the limbs and extremities, the effective dose was generally less than 10 microSv, and for procedures involving the hips and spine it was found that the effective dose could rise to about 1 mSv. Collective doses for each procedure have been calculated to inform prioritization of procedures for local dose reduction strategies.     

Reducing dose at barium enema: radiographers do it digitally

It has been previously shown that, whilst radiographers in our hospital can undertake barium enema examinations with the same degree of diagnostic accuracy as consultant radiologists, there was a dose penalty to the patient arising from the use of a restrictive protocol requiring radiographers to take a series of plain radiographs for reporting purposes. For the past 3 years radiographers at this hospital have worked to a new protocol that replaces all routine radiographs with digital spot films. In the present study, dose-area product (DAP) measurements for 801 barium enema examinations performed by consultant radiologists and radiographers, using the revised protocol, were analysed and compared to ascertain whether there were still significant differences in radiation dose to the patient depending on the category of staff performing the examination. All examinations were reported by a consultant radiologist. The radiologists' reports were analysed against the known outcomes to compare the diagnostic accuracy of the examination when carried out by the two categories of staff. This study shows that using a modified protocol, in which digital spot films replace the series of overcouch radiographs for reporting, our radiographers are able to perform barium enemas without dose penalty to the patient, and without compromizing diagnostic accuracy. Means with 95% confidence intervals for DAP in the two groups were 9.8 Gycm(2) (9.4-10.3 Gycm(2)) and 10.7 Gycm(2) (10.2-11.1 Gycm(2)) for radiographers and radiologists, respectively.     

Digital venography of the lower extremity

A digital 33-cm fluoroscopic system equipped with conventional spot-film and digital or video hard-copy capabilities was evaluated for its usefulness in diagnosing deep venous thrombosis of the lower extremities. The impact of different fluoroscopic field sizes, spatial resolution, and contrast variance was measured by using phantoms. The results indicate that the physical characteristics of the digital system are acceptable for lower-extremity venography. Digital fluoroscopic hard copy was compared with conventional spot films in 22 examinations. The digital examinations were as accurate as the conventional examinations. Procedure time, exposure to radiation, film costs, and repeated injections of contrast medium because of errors in exposure were reduced with the digital method. The need for extra technologists was eliminated. The advantages of digital radiographic displays, postprocessing, storage, and transmission were maximized. Digital fluoroscopic examinations were as accurate as conventional spot films and were found to have many advantages.     

Patient and occupational dose in neurointerventional procedures

Neurointerventional procedures can involve very high doses of radiation to the patient. Our purpose was to quantify the exposure of patients and workers during such procedures, and to use the data for optimisation. We monitored the coiling of 27 aneurysms, and embolisation of four arteriovenous malformations. We measured entrance doses at the skull of the patient using thermoluminescent dosemeters. An observer logged the dose-area product (DAP), fluoroscopy time and characteristics of the digital angiographic and fluoroscopic projections. We also measured entrance doses to the workers at the glabella, neck, arms, hands and legs. The highest patient entrance dose was 2.3 Gy, the average maximum entrance dose 0.9+/-0.5 Gy. The effective dose to the patient was estimated as 14.0+/-8.1 mSv. Other average values were: DAP 228+/-131 Gy cm(2), fluoroscopy time 34.8+/-12.6 min, number of angiographic series 19.3+/-9.4 and number of frames 267+/-143. The highest operator entrance dose was observed on the left leg (235+/-174 microGy). The effective dose to the operator, wearing a 0.35 mm lead equivalent apron, was 6.7+/-4.6 microSv. Thus, even the highest patient entrance dose was in the lower part of the range in which nonstochastic effects might arise. Nevertheless, we are trying to reduce patient exposure by optimising machine settings and clinical protocols, and by informing the operator when the total DAP reaches a defined threshold. The contribution of neurointerventional procedures to occupational dose was very small.